The Alzheimer's Amyloid-Degrading Peptidase, Neprilysin: Can We Control It?
The amyloid cascade hypothesis of Alzheimer's disease (AD) postulates that accumulation in the brain of amyloid β-peptide (Aβ) is the primary trigger for neuronal loss specific to this pathology. In healthy brain, Aβ levels are regulated by a dynamic equilibrium between Aβ release from the amyl...
Main Authors: | N. N. Nalivaeva, N. D. Belyaev, I. A. Zhuravin, A. J. Turner |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | International Journal of Alzheimer's Disease |
Online Access: | http://dx.doi.org/10.1155/2012/383796 |
Similar Items
-
Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer’s disease
by: Natalia N Nalivaeva, et al.
Published: (2014-09-01) -
Amyloid beta and Alzheimer’s Disease: The role of neprilysin-2 in amyloid-beta clearance
by: Robert eMarr, et al.
Published: (2014-08-01) -
The neprilysin (NEP) family of metalloproteinases as amyloid-β peptide degrading enzymes
by: Fisk, Lilia
Published: (2006) -
Hypoxia affects neprilysin expression through caspase activation and an APP intracellular domain-dependent mechanism
by: Caroline eKerridge, et al.
Published: (2015-11-01) -
Role of Prenatal Hypoxia in Brain Development, Cognitive Functions, and Neurodegeneration
by: Natalia N. Nalivaeva, et al.
Published: (2018-11-01)